新诊断高度质瘤的成年人的新辅助药临床试验:系统性审查
Tiffany M Juarez1, Jaya M Gill1, Boris R Minev2
1CureScience Institute, San Diego, CA, USA.
Critical reviews in oncology/hematology
|December 15, 2024
概括
研究高度质瘤的辐射前治疗方法是可行的和安全的. 在放射治疗之前的早期治疗可以确定有效的药物,并评估新诊断的患者的免疫治疗影响.
科学领域:
- 神经瘤学神经瘤学
- 临床试验方法论 临床试验方法论
- 免疫治疗是一种免疫疗法.
背景情况:
- 高度质瘤是具有不良预后的侵袭性脑瘤.
- 像手术和放射化疗这样的标准治疗方法都有局限性.
- 放射治疗可以抑制免疫系统,阻碍免疫疗法并导致复发.
研究的目的:
- 审查新诊断的高度质瘤患者的手术后,辐射前临床试验的可行性,安全性和结果.
- 探索新辅助疗法在辐射诱导免疫抑制之前识别活性剂的潜力.
主要方法:
- 英语临床试验的系统文献综述.
- 搜索了PubMed并引用了相关研究的参考文献.
- 包括涉及新诊断的高度质瘤的成年患者接受放射治疗前术后治疗的试验.
主要成果:
- 确定了在1991年至2024年期间进行的52项临床试验.
- 试验包括各种阶段 (I,II,III,未知),随机化和多中心设计.
- 许多试验调查了基于temozolomide的疗法,共涉及2737名患者.
结论:
- 辐射前的新辅助药研究是可行的,可以确定高度质瘤的活性药物.
- 这种方法对于个性化医学,穿透大脑的药物,向治疗和免疫瘤学至关重要.
- 在辐射之前研究治疗方法可以保护免疫系统和瘤微环境,以便更好地评估.
相关概念视频
Targeted Cancer Therapies
7.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.1K
Treatment Resistant Cancers
2.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.7K
Clinical Trials
8.5K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
8.5K
Clinical Trials: Overview
4.7K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.7K
Drug Administration and Therapy Phases: Overview
2.0K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
2.0K
Therapeutic Drug Monitoring: Overview and Classification
648
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
648


